Quantcast

Latest Niacin Stories

2014-07-30 16:29:33

LEXINGTON, Mass., July 30, 2014 /PRNewswire/ -- Synageva BioPharma Corp. ("Synageva") (NASDAQ: GEVA), a biopharmaceutical company developing therapeutic products for rare disorders, today reported second quarter 2014 financial results, and provided other business updates. Second Quarter 2014 Financial Results For the quarter ended June 30, 2014, Synageva reported a net loss of $50.2 million compared to a net loss of $22.1 million for the corresponding quarter of the prior year....

2014-07-21 12:24:55

Agents That Reduce the Incidence of Cardiovascular Adverse Events Remain a Key Unmet Need for Both Physicians and Payers, According to Findings from Decision Resources Group BURLINGTON, Mass., July 21, 2014 /PRNewswire/ -- Decision Resources Group finds that Amgen's evolocumab (AMG-145) is set to become the clinical gold-standard among statin add-on therapies used to treat patients with dyslipidemia. The competitive advantages this proprotein convertase subtilisin/kexin type 9 (PCSK9)...

2014-07-11 23:08:52

Superior Labs announce the launch of a new product pure Artichoke Leaf Extract dietary supplements to aid in maintaining optimal digestive health by supporting normal bile flow, an action necessary to facilitate metabolism of fat. Newport Beach, CA (PRWEB) July 11, 2014 Superior Labs announce the launch of a new product pure Artichoke Leaf Extract dietary supplements to aid in maintaining optimal digestive health by supporting normal bile flow, an action necessary to facilitate metabolism...

2014-07-10 23:13:05

Announcing the release of our 100% all-natural Vitamin B6 capsules, which are available at the Amazon Marketplace. Unlike similar products on the market, our Vitamin B6, 100 mg capsules are free of the harmful ingredients often utilized in the manufacture of Vitamin B6 supplements. Newport Beach, CA (PRWEB) July 10, 2014 Announcing the release of our 100% all-natural Vitamin B6 capsules, which are available at the Amazon Marketplace. Unlike similar products on the market, our Vitamin B6,...

2014-07-01 23:13:52

NutriGold’s Vitiman C Gold, Whole-Food B Complex Gold, and Triglyceride Omega-3 Gold selected as finalists for the SupplySide 2013 Editor’s Choice awards. (PRWEB) June 30, 2014 Three NutriGold products were named as finalists for SupplySide 2013 Editor’s Choice awards for innovation and market significance: Vitamin C Gold in the category of antioxidant supplements, Whole-Food B Complex Gold in the multivitamin category, and Triglyceride Omega-3 Gold in the Omega-3 category. Vitamin...

2014-07-01 16:29:45

NY Times Article Brings Attention to Dangerous Lifestyle Related Epidemic and Suggests Critical Need for Therapy DENVER, July 1, 2014 /PRNewswire/ -- A recent New York Times article ("Threat Grows from Liver Illness Tied to Obesity", June 13 2014) alerting millions to the growing prevalence and seriousness of fatty liver disease revealed a stark and very concerning reality about therapeutic options. There are currently no drugs approved for either NAFLD (nonalcoholic fatty liver...

2014-07-01 16:25:38

LONDON, July 1, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Nicotine Addiction - Pipeline Review, H1 2014http://www.reportbuyer.com/pharma_healthcare/therapeutic/nicotine_addiction_pipeline_review_h1_2013.html Nicotine Addiction - Pipeline Review, H1 2014 SummaryGlobal Markets Direct's, 'Nicotine Addiction - Pipeline Review, H1 2014', provides an overview of the Nicotine Addiction's therapeutic pipeline.This report provides comprehensive information...

2014-06-30 16:26:45

Phase 3 Study Meets Primary Endpoint and Six Secondary Endpoints Across Multiple Disease-Related Abnormalities LEXINGTON, Mass., June 30, 2014 /PRNewswire/ -- Synageva BioPharma Corp. (Synageva) (NASDAQ: GEVA), a biopharmaceutical company developing therapeutic products for rare diseases, announced today that the global, randomized, double-blind, placebo-controlled Phase 3 ARISE trial of sebelipase alfa in 66 children and adults with lysosomal acid lipase deficiency (LAL...

2014-06-24 08:30:56

Achievement of LDL Particle Targets Associated with More Aggressive Lipid-lowering Therapy and Better Clinical Outcomes Compared to Patients Managed to LDL Cholesterol Targets RALEIGH, N.C., June 24, 2014 /PRNewswire/ -- LipoScience, Inc. (NASDAQ: LPDX), today announced the publication of the first large-scale real world study evidencing a link between low LDL-P and reduced cardiovascular disease (CVD) risk. Data in the study published in Atherosclerosis demonstrated that high-risk...

2014-06-16 09:46:15

American Diabetes Association Panelists will argue pros and cons at symposium New guidelines for the treatment of high cholesterol are not appropriate for people with type 2 diabetes – or are they? Two researchers will debate the topic at a symposium to be held on Tuesday, June 17, at the American Diabetes Association's 74th Scientific Sessions®. At issue are the newest guidelines issued jointly by the American College of Cardiology and American Heart Association in November...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.